Novel Mannich base 3FB3FA8H induces apoptosis by upregulating P53 pathway in neuroblastoma cells

Area of Science:

• Molecular Biology
• Cancer Research
• Pharmacology

Background:

• The P53 gene is crucial for genetic stability and tumor suppression.
• P53 pathway dysregulation is implicated in neuroblastoma development, enabling cancer cells to evade apoptosis.
• Activating the P53 pathway presents a potential therapeutic avenue for neuroblastoma.

Purpose of the Study:

• To investigate the efficacy of a novel Mannich base, 3FB3FA8H, in targeting the P53 pathway.
• To evaluate 3FB3FA8H's potential as a therapeutic agent for neuroblastoma.

Main Methods:

• Administration of the novel Mannich base (3FB3FA8H) to neuroblastoma cells.
• Analysis of P53 pathway modulation, including mRNA levels of P53 and BAX.
• Assessment of mitochondrial membrane permeability and caspase 3 cleavage.
• Evaluation of the BAX/BCL2 ratio.

Main Results:

• 3FB3FA8H modulated the P53 pathway, leading to neuroblastoma cell apoptosis.
• Increased mitochondrial membrane permeability was observed following 3FB3FA8H treatment.
• 3FB3FA8H elevated P53 mRNA levels, activating BAX and promoting apoptosis via caspase 3 cleavage.

Conclusions:

• The Mannich base 3FB3FA8H effectively induces P53-mediated apoptosis in neuroblastoma cells.
• This P53-activating mechanism holds significant potential for reducing tumor burden in neuroblastoma patients.
• 3FB3FA8H represents a promising candidate for future neuroblastoma therapies.